# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-274241
Filing Date
2025-11-10
Accepted
2025-11-10 16:11:00
Documents
76
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | fgen-20250930.htm iXBRL | 10-Q | 3363999
2 | EX-10.1 | fgen-ex10_1.htm | EX-10.1 | 58413
3 | EX-10.2 | fgen-ex10_2.htm | EX-10.2 | 268706
4 | EX-10.3 | fgen-ex10_3.htm | EX-10.3 | 82167
5 | EX-31.1 | fgen-ex31_1.htm | EX-31.1 | 10443
6 | EX-31.2 | fgen-ex31_2.htm | EX-31.2 | 10437
7 | EX-32.1 | fgen-ex32_1.htm | EX-32.1 | 10431
| Complete submission text file | 0001193125-25-274241.txt |  | 12698652

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | fgen-20250930.xsd | EX-101.SCH | 1986805
79 | EXTRACTED XBRL INSTANCE DOCUMENT | fgen-20250930_htm.xml | XML | 1923800

Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 251466289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)